Kiniksa Pharmaceuticals International, plc
KNSA
Classifica tra le azioni
#2944
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company,... Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
Prezzo delle azioni
$80.10
Ultima sincronizzazione: 2026-10-21
Capitalizzazione di mercato
$6.25B
Variazione (1 giorno)
-3.69%
Variazione (1 anno)
105.92%
Paese
GB
Scambia Kiniksa Pharmaceuticals International, plc (KNSA)
Categoria
Healthcare
Storico del prezzo dell'azione per Kiniksa Pharmaceuticals International, plc (KNSA)
Prezzo di chiusura più alto: $78.59 il 2026-10-01
Prezzo di chiusura più basso: $18.08 il 2018-05-01
Prezzo di chiusura più basso: $18.08 il 2018-05-01
Storico del prezzo dell'azione di Kiniksa Pharmaceuticals International, plc dal 2018 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2026 (TTM) | 31.83% |
| 2025 | 101.55% |
| 2024 | 16.14% |
| 2023 | 13.98% |
| 2022 | 22.63% |
| 2021 | -31.53% |
| 2020 | 57.49% |
| 2019 | -47.95% |
| 2018 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $62.20 | 68.82% |
US
|
|
| $46.29 | 37.83% |
SE
|
|
| $171.04 | 23.67% |
FR
|
|
| $116.39 | 58.03% |
US
|
|
| $59.46 | -0.57% |
IT
|
